Potsdam, NYNCT07034196Now EnrollingIRB Ready

Rheumatoid Arthritis (RA Clinical Trial in Potsdam, NY

Access cutting-edge rheumatoid arthritis (ra treatment through this clinical trial at a research site in Potsdam. Study-provided care at no cost to qualified participants.

Sponsored by St. Lawrence Health System

Quick Self-Assessment

See if you qualify for this Potsdam location

Preparing your pre-screening questions…

Expert Care in Potsdam

Access rheumatoid arthritis (ra specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related rheumatoid arthritis (ra treatment provided free

Apply for This Potsdam Location

Check if you qualify for this rheumatoid arthritis (ra clinical trial in Potsdam, NY

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Potsdam

    Convenient for NY residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Potsdam site if eligible
  4. 4Begin participation

About This Rheumatoid Arthritis (RA Study in Potsdam

Rheumatoid arthritis (RA) is a complex autoimmune disease where the immune system attacks healthy joint tissue; causing pain, swelling, and stiffness of the joints. This disease effects lots of people in the US and can lead to major joint damage if not properly treated. In rural areas like northern NY, these are underserved areas for RA patients, thus many patients struggle to get the appropriate care. This model is testing whether primary care providers (PCP) can safely and effectively provide stable RA patients with the proper treatment rather than send them to a specialist. PCPs were trained through classes, case reviews, and a final exam. Patients will be randomly assigned to either see a trained PCP or their normal rheumatologist at the rheumatology clinic. This study will examine how patients are doing over a year using medical exams and patient feedback. If this model proves to be successful, it will make RA treatment easier and more affordable for patients.

Sponsor: St. Lawrence Health System

Who Can Participate

Inclusion Criteria

Fulfillment of the 2010 ACR/EULAR classification criteria for rheumatoid arthritis Using these criteria, a classification as "definite RA" is based upon the presence of synovitis in at least one joint, the absence of an alternative diagnosis that better explains the synovitis, and the achievement of a total score of at least 6 (of a possible 10) from the individual scores in four domains. The highest score achieved in a given domain is used for this calculation. These domains and their values are:
Number and site of involved joints:
2 to 10 large joints (from among shoulders, elbows, hips, knees, and ankles) = 1 point
1 to 3 small joints (from among the MCP joints, PIP joints, second through fifth MTP joints, thumb IP joints, and wrists) = 2 points
4 to 10 small joints = 3 points
Greater than 10 joints (including at least 1 small joint) = 5 points
Serological abnormality (RF or ACPA)
Low positive (above the upper limit of normal) = 2 points
High positive (greater than three times the upper limit of normal) = 3 points
Elevated acute phase response (ESR or CRP) above the upper limit of normal = 1 point
Symptom duration at least six weeks = 1 point
Stable disease activity, defined as a RAPID-3 score of no higher than 4 over the past three months or no RA-related medication changes for at least six months prior to the informed consent date.
Primary residence in the North Country region of New York (Jefferson, Lewis, St. Lawrence, Clinton, Essex, Franklin, and Hamilton counties).
Established with the participating rheumatology clinic and a participating PCP (Note: For patients who are established in PCP clinics outside of the health system conducting this study, patients may see a participating PCP within their established clinic). To be considered an established patient, the participant should have had a visit within the year prior to the screening visit.
Willingness to participate in the study and provide informed consent.
Females of childbearing potential must agree to use highly effective birth control throughout duration of the study.

Exclusion Criteria

Changes in RA treatment within the six months prior to screening.
History of interstitial lung disease or any manifestation of rheumatoid vasculitis including cutaneous rheumatoid vasculitis, vasculitic neuropathy, RA-associated episcleritis, scleritis or keratitis)
Cognitive impairment or inability to complete study assessments.
Pregnancy, breastfeeding, or plans to become pregnant during the study period.
Inability to adhere to the study protocol or follow-up requirements.
Any comorbid condition that, in the opinion of the investigator, would make the subject unsuitable for participation in this study.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Potsdam?

Yes, this clinical trial (NCT07034196) has an active research site in Potsdam, NY that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Rheumatoid Arthritis (RA Treatment Options in Potsdam, NY

If you're searching for rheumatoid arthritis (ra treatment options in Potsdam, NY, this clinical trial (NCT07034196) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Potsdam research site is actively enrolling participants for this clinical trial. You'll receive care from experienced rheumatoid arthritis (ra specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all rheumatoid arthritis (ra clinical trials near you to find additional studies recruiting in your area.

More Rheumatoid Arthritis Trials in Potsdam, NY

See all rheumatoid arthritis clinical trials recruiting in Potsdam — not just this study.

Browse Rheumatoid Arthritis Trials in Potsdam

Ready to Join in Potsdam?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Potsdam, NY